Mutant p53 aggregates trigger not only the co-aggregation of wild-type p53 (dominant-negative effect) [15] but also the cross-reaction of its two homologues p63 and p73 (gain-of-function effect) [16,17], which makes the cancer cells more aggressive [18,19]. The gene discussed is TP53; the disease is cancer.